FARIBORZ DAVOODI: Open Payments
NPI 1811924343 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 39 payments from 14 companies in 2025. Trend: 2023 $572 · 2024 $803 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $141 |
| Antares Pharma, Inc. | 5 | $101 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| PFIZER INC. | 3 | $65 |
| Lilly USA, LLC | 3 | $49 |
| HARMONY BIOSCIENCES LLC | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $34 |
| TOLMAR, INC. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: XYOSTED, TRELEGY ELLIPTA, UBRELVY, NURTEC ODT, QULIPTA, WAKIX, OTEZLA, JARDIANCE.
Industry payments across CO — which companies pay providers there.
